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Abstract Single C motif-1 (SCM-1)/lymphotactin is a C-type
member of the chemokine superfamily. Previously, we identified
its specific receptor XCR1. Here we isolated the murine
homologue of XCR1 (mXCR1). To demonstrate its biological
activity, we produced recombinant mouse SCM-1 by the
baculovirus expression system. B300-19 murine pre-B cells
expressing mXCR1 responded to mSCM-1 in chemotactic and
calcium-mobilization assays. mXCR1 mRNA was weakly
expressed in spleen and lung of normal C57BL/6 mice. In spleen,
CD8+ cells and NK1.1+ cells were found to express mXCR1.
Identification of mXCR1 will now allow us to study the role of
this unique cytokine system in the mouse models of inflammation
and immunity.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Single C motif-1 (SCM-1)/lymphotactin/activation-induced,
T cell-derived and chemokine-related molecule (ATAC) is a
novel cytokine with structural homology to chemokines, espe-
cially to the CC subfamily, but lacking the ¢rst and third of
the four canonical cysteine residues conserved in all other
chemokines [1^4]. In humans, there are two highly homolo-
gous SCM-1 genes, SCYC1 and SCYC2, which are localized
close together on chromosome 1q23 and encode two SCM-1
proteins, SCM-1K and SCM-1L, with only two amino acid
di¡erences [5]. The biological functions as well as pathophys-
iological roles of SCM-1 are still mostly unknown. It was
reported to be chemotactic for lymphocytes and NK cells
[1,4,6,7]. However, its chemotactic activity is still controversial
[8]. It is selectively expressed by activated CD8 T cells and
double negative KL-type thymocytes [1,3,4]. Furthermore, epi-
dermal dendritic QN-type T cells and intestinal intraepithelial
QN-type T cells were found to produce copious amounts of this
cytokine upon activation [9]. Interleukin 2 (IL-2)-activated
murine NK cells and human NK clones were also found to
express its mRNA [7]. Thus, SCM-1/lymphotactin/ATAC is a
unique cytokine whose expression is highly selective for cer-
tain subsets of T cells and NK cells.
Previously, we have identi¢ed a seven transmembrane G
protein-coupled receptor speci¢c for human SCM-1K
and SCM-1L, and termed it XCR1 following the set rule of
chemokine receptor nomenclature [10]. SCM-1 showed a high-
a⁄nity binding to XCR1 with a Kd of 10 nM and induced
vigorous chemotaxis and calcium mobilization in XCR1-
transfected murine L1.2 cells [10]. Northern blot analysis of
various human tissues revealed that XCR1 mRNA was ex-
pressed strongly in placenta and weakly in spleen and thymus
[10]. Hardly any signals were, however, detected in peripheral
blood lymphocytes even after a long exposure. Thus, the cells
expressing XCR1 appear to be associated with particular tis-
sues but are rarely present in the blood. This makes identi¢-
cation of the cells expressing XCR1 in humans rather di⁄cult.
Thus, we decided to identify the mouse counterpart of XCR1
and to study the biological roles of this unique cytokine sys-
tem in the murine models. Here, we report the identi¢cation
and preliminary characterization of the murine homologue of
XCR1 termed mXCR1.
2. Materials and methods
2.1. Cells and chemokines
The murine pre-B cell line B300-19 was kindly provided by Dr. H.
Kawasaki at Tokyo University and maintained in RPMI 1640 sup-
plemented with 10% fetal calf serum. Recombinant mouse SCM-1 was
produced by using a baculovirus expression system and puri¢ed to
homogeneity as described previously [10]. N-Glycanase and O-glycan-
ase were purchased from Genzyme (Boston, MA, USA).
2.2. Southern blot analysis
This was carried out using DIG High Prime DNA Labeling and
Detection Starter Kit II (Boehringer Mannheim). In brief, 25 Wg of
DNA from the liver of a C57BL/6 mouse was digested with HindIII.
Digested DNA was fractionated by electrophoresis on 0.7% agarose
gel and transferred onto a positively charged nylon membrane (Boehr-
inger Mannheim) in alkaline conditions. Human XCR1 cDNA [10]
was labeled with digoxigenin by the random priming method and used
as a probe. Hybridization was carried out at 42‡C for 15 h and
hybridized bands were detected following the manufacturer’s proto-
col.
2.3. Isolation of the mXCR1 genomic clone
A Lambda Fix II 129SVJ mouse liver genomic phage library (Stra-
tagene) was plated on Escherichia coli strain XL1-Blue at a density of
4U104 plaques/plate. Filter lifts from 20 plates were screened with
32P-labeled human XCR1 cDNA [10]. DNA from a positive clone
was digested with EcoRI, subcloned into pBluescript II (Stratagene),
and sequenced on both strands. The nucleotide sequence has been
deposited in DDBJ/EMBL/GenBank with accession number
AB028459.
2.4. Construction of the receptor expression plasmid
The coding region of mXCR1 was ampli¢ed from the mouse ge-
nomic clone by polymerase chain reaction (PCR) using speci¢c prim-
ers (+ 5P-CTCGAGGCCATGGAGTCCTCTACAG-3P and 3 5P-
TTGCGGCCGCTCCTCTCAGTAGAAGGAGGG-3P) and sub-
cloned into pCRIITA vector. After con¢rmation of the sequence,
the coding region was recloned into a retrovirus vector (pMX-I/E)
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to generate pMX-I/E-mXCR1. pMX-I/E was generated from pMX
[11] by inserting the internal ribosome entry site (IRES) (Clontech)
and the coding sequence for enhanced green £uorescent protein
(EGFP) (Clontech).
2.5. Stable expression of mXCR1
BOSC23 cells obtained from ATCC were seeded into 60 mm dishes
(2U106 cells/dish) 1 day before transfection. The cells were transfected
with pMX-I/E-mXCR1 or pMX-I/E using Lipofectamine (Gibco-
BRL) and cultured for 48 h. The supernatants containing the re-
combinant retroviruses were then used to infect B300 cells to isolate
cells stably expressing mXCR1. In brief, 1.1U105 B300 cells were
incubated with 3 ml of virus stock in the presence of 10 mg/ml of
polybrene for 8 h. Cells expressing EGFP were counted under a £uo-
rescent microscope before use.
2.6. Chemotaxis assay
Migration of control and mXCR1-expressing B300 cells was as-
sessed in Transwell plates (Costar) with 3 Wm pores. After incubation
at 37‡C for 4 h, cells migrating into lower wells were counted as
described previously [10].
2.7. Calcium mobilization assay
This was carried out as described previously [10]. In brief, cells
loaded with Fura-2/AM (Molecular Probes, Eugene, OR, USA)
were placed in a cuvette (1U106 cells/300 Wl) and kept at 37‡C with
constant stirring on a spectro£uorimeter (F-2500, Hitachi, Japan).
Following addition of mSCM-1, the £uorescence intensity ratio
(R340=380) was monitored by measuring emission £uorescence at 510
nm upon excitation at 340 nm and 380 nm with a time resolution of
5 points/s.
2.8. Northern blot analysis
This was carried out as described previously [10]. A multi-tissue
Northern blot ¢lter was purchased from Clontech. The mXCR1 probe
of 1.2 kb was generated by PCR using speci¢c primers described
above.
2.9. Cell fractionation
Female C57BL/6 mice were purchased from Clea Japan (Osaka)
and used at about 7 weeks of age. Spleen cells were mechanically
dispersed and cells with indicated surface markers were puri¢ed by
magnetic cell sorting using MACS (Miltenyi Biotech, Germany). In
brief, CD4 cells, CD8 cells, and B220 cell were positively selected
on a VS separation column (Miltenyi) after labeling with anti-CD4
microbeads, anti-CD8 microbeads, and anti-B220 microbeads, respec-
tively. For isolation of macrophages, plastic adherent cells were re-
suspended with EDTA treatment and vigorous pipetting, stained with
FITC-conjugated F4/80 (Pharmingen), and positively selected on a VS
column after labeling with anti-FITC microbeads (Miltenyi). For iso-
lation of NK cells, spleen cells were double-stained with biotinylated
anti-CD3 and FITC-conjugated anti-NK1.1. CD3 cells were nega-
tively selected on a BS depletion column (Miltenyi) after reacting with
streptavidin microbeads. Subsequently, NK1.1 cells were positively
selected on a VS column after reacting with anti-FITC microbeads.
The purity of each cell fraction was examined on a £ow cytometer
after staining with FITC-labeled antibodies to respective cell surface
markers.
2.10. RT-PCR
Cells were lysed with Trizol (Gibco-BRL) and total RNA was pu-
ri¢ed by using RNeasy (Qiagen). Total RNA from each cell fraction
(290 ng) was reverse transcribed by using 6 pmol of oligo(dT)18 prim-
er and SuperScript II reverse transcriptase (Gibco-BRL). The result-
ing ¢rst-strand DNA (15 ng of total RNA equivalent) and original
total RNA (15 ng) were subjected to PCR ampli¢cation in a ¢nal
volume of 20 Wl containing 10 pmol of each primer and 1 unit of
Ex-Taq polymerase (TaKaRa, Japan). Primers used were: + 5P-
ATACCTGTCTGTAGTGAGC-3P and 3 5P-AAAGCACTGGGTT-
GAAACA-3P for mXCR1; + 5P-ATGGATGACGATATCGCT-3P
and 3 5P-ATGAGGTAGTCTGTCAGGT-3P for mouse L-actin.
PCR was carried out by 30 cycles of denaturation at 94‡C for 30 s,
annealing at 55‡C for 30 s, and extension at 72‡C for 30 s. Ampli¢-
cation products (6 Wl each) were separated by 2% agarose and stained
with ethidium bromide.
3. Results and discussion
3.1. Identi¢cation of mouse XCR1
The genomic DNA derived from a C57BL/6 mouse was
digested with HindIII and subjected to Southern blot analysis
using the human XCR1 cDNA [10] as a probe. A 2 kb band
was detected even by hybridization at high stringency condi-
tions (data not shown). This suggested the presence of a gene
in the mouse genome that was highly homologous to human
XCR1. We therefore screened a mouse liver genomic library
using XCR1 cDNA as a probe. A positive clone was isolated
and the 11 kb insert was sequenced. The clone contains a long
open reading frame without introns encoding a putative seven
transmembrane G protein-coupled receptor. There are two
potential initiation codons with an in-frame stop codon in
the upstream region. Since the second ATG, but not the ¢rst
ATG, conforms to Kozak’s rule [12] and also corresponds to
the ¢rst ATG of the human sequence, we postulate that the
translation starts from the second ATG. The encoded protein
of 322 amino acids has seven transmembrane regions and an
acidic N-terminus, the features common to other chemokine
receptors (Fig. 1). The predicted amino acid sequence shows
the highest homology with human XCR1 with 71% identity.
The murine sequence has no N-glycosylation site in the puta-
tive extracellular domains as the human sequence. Further-
more, the DRYLAIV motif in the second intracellular do-
main, which is highly conserved in other chemokine
receptors and is involved in G protein docking [13], is altered
Fig. 1. Alignment of the amino acid sequences of mXCR1 and hu-
man XCR1. The amino acid sequence of mXCR1 is deduced from
the coding sequence of the mXCR1 genomic clone. Gaps are
marked by dashes. Identical residues are indicated by colons. TM,
transmembrane regions. The sequence corresponding to the DRY
motif is boxed.
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to HRYLSVV in both human and murine XCR1. This prob-
ably a¡ects their coupling with G protein partners. From
these and other results described below, we concluded that
the sequence represents the murine counterpart of XCR1
(mXCR1).
3.2. Production of recombinant mouse SCM-1
In order to test the biological activity of mXCR1, we gen-
erated recombinant murine SCM-1 (mSCM-1) by the baculo-
virus expression system. Insect High Five cells were infected
with a recombinant baculovirus encoding mSCM-1 under the
control of the polyhedrin promoter. Secreted mSCM-1 in the
culture supernatants was puri¢ed by cation exchange chroma-
tography, heparin a⁄nity chromatography and reverse phase
high performance liquid chromatography (HPLC). As shown
in Fig. 2A, mSCM-1 was eluted as a single peak from HPLC.
The puri¢ed mSCM-1 migrated as a broad band of 15 kDa on
a gradient SDS-PAGE (Fig. 2B). The N-terminal amino acid
sequence analysis revealed that the mature mSCM-1 started at
valine 22 like human recombinant SCM-1 and natural ATAC
[8,10]. Treatment with O-glycanase but not with N-glycanase
reduced the molecular mass by about 1 kDa (Fig. 2C). This
showed that mSCM-1 was O-glycosylated as reported for
human natural ATAC [10].
3.3. Induction of chemotaxis and calcium mobilization by
mSCM-1 via mXCR1
To determine the ability of mSCM-1 to signal via mXCR1,
we stably expressed mXCR1 in the murine pre-B cell line
B300-19 by using a retrovirus vector encoding mXCR-1 and
GFP. Control cells were infected with a retrovirus vector en-
coding GFP only. After infection, GFP-expressing cells were
found to be about 20% and 40%, respectively. As shown in
Fig. 3A, mSCM-1 induced a vigorous chemotactic response in
mXCR-1-expressing cells but not in control cells with a typ-
ical bimodal dose-response curve and a maximal response at
100 ng/ml (10 nM). A checkerboard-type analysis con¢rmed
Fig. 2. Puri¢cation of recombinant mSCM-1. A: Elution pro¢le of
mSCM-1 on reverse phase HPLC. B: Silver staining of puri¢ed
mSCM-1 on SDS-PAGE. F, the peak fraction eluted from Hitrap
heparin; H, the peak fraction eluted from reverse phase HPLC. C:
Deglycosylation of mSCM-1. Puri¢ed mSCM-1 was treated without
or with N-glycanase or O-glycanase. After SDS-PAGE, silver stain-
ing was done. 1, untreated; 2, treated with N-glycanase; 3, treated
with O-glycanase. The molecular weight markers are shown on the
right (kDa).
Fig. 3. Chemotactic response of mXCR1-expressing murine B300-19
pre-B cells. A: Dose-response experiments. Vector-transfected
(closed squares) or mXCR1-transfected (open circles) B300-19 cells
were placed in the upper wells of Transwell plates. mSCM-1 was
added to the bottom wells at indicated concentrations. After incuba-
tion at 37‡C for 4 h, the cells that had migrated into bottom wells
were counted under the microscope. The assays were done in tripli-
cate. Each point represents mean þ S.E.M. from three separate ex-
periments. B: A checkerboard-type analysis. In the chemotaxis as-
says using mXCR1-expressing B300 cells, mSCM-1 was added to
the upper and/or lower wells at 100 ng/ml as indicated. The assays
were done in triplicate. Each point represents mean þ S.E.M. from
three separate experiments.
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that the migration of mXCR1-expressing B300-19 cells toward
mSCM-1 was mostly chemotactic (Fig. 3B). As shown in Fig.
4, mSCM-1 also induced calcium mobilization in mXCR1-
expressing B300-19 cells in a dose-dependent manner. B300-
19 cells expressing only GFP alone did not show any such
response to mSCM-1 (data not shown). These results clearly
demonstrate that mXCR1 is a functional receptor for mSCM-
1.
3.4. Expression of mXCR1 in tissues and cells
Expression of mXCR1 in various mouse tissues was studied
by Northern blot analysis. As shown in Fig. 5, weak signals of
a 2.4 kb band were detected in spleen and lung after a long
exposure. To further de¢ne the types of cells expressing
mXCR1, we fractionated spleen cells obtained from C57BL/
6 mice by using various surface markers. The expression of
mXCR1 was analyzed by RT-PCR. As shown in Fig. 6,
mXCR1 expression was detected in cells with CD8 marker
and also weakly in NK cells (NK1.1CD33). No signals
were detected without reverse transcription (not shown), ex-
cluding contamination of genomic DNA. Thus, CD8 cells
and NK cells appear to express mXCR1.
The expression of mXCR1 in CD8 cells and NK1.1 cells
is rather striking because these types of cells are also consid-
ered to be the main producers of SCM-1 [1,3,4,7,9]. However,
self-recruitment through secretion of self-reactive chemokines
appears to be rather common among various leukocytes
[13,14]. The weak signals obtained from the fractionated cells
even by RT-PCR might also suggest that only a subset of cells
with these markers do express mXCR1. Generation of anti-
bodies to mXCR1, which is now in progress in our labora-
tory, will allow us to identify the exact types of cells that
express mXCR1 and respond to mSCM-1.
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Fig. 4. Calcium mobilization in mXCR1-expressing B300-19 cells by
mSCM-1. mXCR1-expressing B300-19 murine pre-B cells were
loaded with Fura-2/AM and stimulated with mSCM-1 as indicated.
The data shown are representative of three separate experiments.
The scale bar (0.2) is shown on the right.
Fig. 5. Expression of mXCR1 mRNA in various mouse tissues. A
¢lter blotted with 2 Wg/lane of poly(A) RNA from indicated mouse
tissues (Clontech) was hybridized with the 32P-labeled cDNA probe
for mXCR1. For autoradiography, exposure was done at 380‡C for
7 days with an intensifying screen.
Fig. 6. RT-PCR analysis of mXCR1 expression in fractionated
spleen cells. Total RNA was isolated from the indicated cell frac-
tions, reverse transcribed and subjected to PCR ampli¢cation using
mXCR1 speci¢c primers. Simultaneously, ampli¢cations of L-actin
were performed as an internal control. Ampli¢cation products were
run on 2% agarose gel and stained with ethidium bromide. Repre-
sentative results from two separate experiments are shown. The pu-
rity of each cell fraction used was as follows: CD4, 95.1%; CD8,
94.5%; B220, 97.1%; macrophages, 81.6%; NK1.1CD33 cells,
88%.
FEBS 22558 1-9-99
T. Yoshida et al./FEBS Letters 458 (1999) 37^4040
